Streamlining Collaboration and Development for Neglected Diseases Drug Discovery Using CDD Vault

webinar

Tue, 13 Jul 2021, 16:00 CEST (Berlin)

Dr. Kelly Bachovchin, Collaborative Drug Discovery, USA

Streamlining Collaboration and Development for Neglected Diseases Drug Discovery Using CDD Vault

We are happy to announce a guest speaker webinar by Kelly Bachovchin from our friends at Collaborative Drug Discovery. CDD provide a whole solution for today’s biological and chemical data needs, differentiated by ease-of-use and a strong focus on collaborative capabilities. Efforts to develop new drugs to treat neglected tropical diseases are limited and therefore rely on collaborations between academic and industrial institutions. Kelly will speak about how they help share up-to-date information and data — which is pertinent for these types of collaborations.

CDD Vault®, a cloud-based software, includes activity & registration, visualization, inventory, and ELN capabilities.  Researchers can archive, mine, and securely collaborate within CDD Vault.  Collaborative hypothesis generation and evaluation allow multiple perspectives for multi-parameter optimization.

CDD vault helps to streamline the drug discovery process, and Kelly will show this with a real world example. CDD, being a key player in modern state-of-the-art drug discovery, has contributed to many breakthroughs in various projects; should you be curious about A.I. integration in our discipline —  then an excellent talk on machine learning in drug discovery can be accessed here.

Current news

category
Software
Make It Double! — SeeSAR and HPSee Updates
October 14, 2026 08:00 CEST
The SeeSAR 15.1 and HPSee 2.4 Updates SeeSAR 15.1 ‘Apollo’ and HPSee 2.4 ‘Electra’ are here! The double release brings per-synthon estimates of extension result counts to Chemical Space Docking and new reference-molecule support and automatic best-spot selection to Activity Spotter. Alongside these additions, faster molecule transfers and more flexible...
Read on
Entering The Trillion Era: AMBrosia Update
October 7, 2026 13:24 CEST
More chemistry. Trillions of possibilities. AMBrosia enters its third version with more than 2.4 trillion virtual product molecules. Developed in close collaboration with Ambinter (a brand of Greenpharma), the expanded Chemical Space combines 313,777 building blocks through 54 chemical reactions, implemented as 131 technical reactions, opening up a wealth of...
Read on
category
Events
DrugSpace 2026 Symposium - The Path to Digital Chemistry
October 6, 2026 11:28 CEST
Where Medicinal and Computational Chemistry Come Together We are delighted to invite drug hunters, compound enthusiasts, and molecule designers back to the virtual DrugSpace Symposium. The fifth edition takes place on December 9, 2026, under the theme “The Path to Digital Chemistry,” and turns the spotlight on where computational and...
Read on